The Global Core Biopsy Needles Market Size Is Projected To Grow At A CAGR Of 5.5% During The Forecast Period 2022-2030.

Core Biopsy Needles Market Overview:

A biopsy is a surgical procedure in which tissue is removed from an organ to determine the presence or extent of disease. Surgeons, radiologists, and interventional cardiologists are the most common people who do this. Biopsies of body organs such as lungs, liver, and kidneys are performed using a biopsy device. A biopsy needle is a device specifically designed to remove small amounts of tissue from the body for diagnostic testing. Biopsy procedures are done for a variety of reasons: to examine a lump or mass, to determine whether a suspicious area is cancerous or benign, or to evaluate an organ for transplant.

Core Biopsy Needles market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Core Biopsy Needles market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Major Market Segments Covered in Core Biopsy Needles Industry Research:

Market Key Players:
BD, Hologic, Inc., Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, INVIVO THERAPEUTICS, MDL SRL., STERYLAB S.r.l., UROMED Kurt Drews KG, BPB medica, Koninklijke Philips N.V., Medtronic, GENERAL ELECTRIC COMPANY, Leica Biosystems Nussloch GmbH, ZAMAR CARE., Stryker, Messe Düsseldorf GmbH, Kompass, COMPASS International Innovations, Inc., HAKKO CO.,LTD. and Cardinal Health

By Type:

• Full- automated core needle biopsy device
• Semi- automated core needle biopsy device

By Range:

• 14G- 18G
• <14G and >18G

By Disease:

• Lung Cancer
• Liver Cancer
• Breast Cancer
• Prostate Cancer
• Other

By Application:

• Hospitals
• Clinics
• Others

By Region:

North America dominates the core needle biopsy market owing to the prevalence of sophisticated healthcare infrastructure, increased research and development proficiencies by the pharmaceutical companies and rapid adoption of new and better healthcare technologies. Asia-Pacific on the other hand is projected to score highest growth rate for the forecast period owing to rising expenditure to develop healthcare infrastructure, rising prevalence of cancer and rising geriatric population susceptible to cancer.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Significant Market Dynamics:

Drivers:

Increased prevalence of human and animal cancers.

Growing elderly population worldwide.

Initiatives taken by governments to spread cancer awareness will boost the growth of the market.

Restraints:

High cost of biopsy devices.

Lack of availability of skilled professionals.

Core Biopsy Needles Market report scope:

Report Attributes	Details
Growth Rate	CAGR of 5.5% from 2022 to 2030.
By Type	Full- automated core needle biopsy device, Semi- automated core needle biopsy device
By Application	Hospitals, Clinics, Others
By Companies	BD, Hologic, Inc., Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, INVIVO THERAPEUTICS, MDL SRL., STERYLAB S.r.l., UROMED Kurt Drews KG, BPB medica, Koninklijke Philips N.V., Medtronic, GENERAL ELECTRIC COMPANY, Leica Biosystems Nussloch GmbH, ZAMAR CARE., Stryker, Messe Düsseldorf GmbH, Kompass, COMPASS International Innovations, Inc., HAKKO CO.,LTD. and Cardinal Health
Regions and Countries Covered	North America: (US, Canada, Mexico, Rest of North America) Europe(Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe) Asia-Pacific (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific) The Middle East & Africa(Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa) Latin America(Brazil, Argentina, Rest of Latin America) Rest Of the World
Base Year	2022
Historical Year	2017 to 2022
Forecast Year	2023 to 2030

Key Takeaways from this Core Biopsy Needles Report

• Estimate Core Biopsy Needles market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
• Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
• Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
• Get a quick viewpoint on the Core Biopsy Needles market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
• Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
• Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Study the sales and distribution channels over key geographies to improve top-line revenues.

Frequently Asked Questions-

What is the CAGR of Core Biopsy Needles market?

The Core Biopsy Needles Market is growing at a CAGR of 5.5% During Forecast Period.

What are the key types of Core Biopsy Needles market?

Full- automated core needle biopsy device, Semi- automated core needle biopsy device

What are the key applications of Core Biopsy Needles market?

Hospitals, Clinics, Others

Who are the key players in Core Biopsy Needles market?

BD, Hologic, Inc., Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, INVIVO THERAPEUTICS, MDL SRL., STERYLAB S.r.l., UROMED Kurt Drews KG, BPB medica, Koninklijke Philips N.V., Medtronic, GENERAL ELECTRIC COMPANY, Leica Biosystems Nussloch GmbH, ZAMAR CARE., Stryker, Messe Düsseldorf GmbH, Kompass, COMPASS International Innovations, Inc., HAKKO CO.,LTD. and Cardinal Health